Health maintenance includes secondary prevention through cancer screening,
There are no established guidelines for cancer screening patients with end-
stage renal disease (ESRD), Using an established method of estimating life
expectancy, published literature on cancer screening, and information from
databases on mortality and malignancy (US Renal Data System 1997 Annual Dat
a Report and the SEER Cancer and Statistical Review, 1973-1994), a "real-ti
me life expectancy calculator" was developed to guide the primary help prov
ider in making informed decisions on the benefits of cancer screening in in
dividual patients. Potential days of life saved by each screening method ca
n be calculated using the difference in life expectancy per the DEALE (decl
ining exponential approximation of life expectancy) method with and without
cancer screening. Using two sets of assumptions (one to enhance any bias t
oward support for screening and one to limit this bias), a range of potenti
al days of life saved with screening for breast and colon cancer can be cal
culated in individual patients with ESRD, In breast cancer, for example, a
50-year-old black woman with ESRD and multiple risk factors would have 41 t
o 291 potential days of life saved with screening, A 60-year-old white woma
n with ESRD and diabetes mellitus (DM) would have only 1 to 16 days of life
saved, This life expectancy calculator can guide the primary health care p
rovider in making clinical decisions concerning screening in the ESRD popul
ation. In addition to assisting in patient education, the calculator can be
updated as new information becomes available regarding relative risk, trea
tment, and mortality. This is a US government work. There are no restrictio
ns on its use.